'Living' History: Breakthrough CAR-T Application Breaks Through In National Media

14 Jul 2017

• By Michael McCaughan

FDA advisory committee meetings aren’t often front page news. But the Oncologic Drugs Advisory Committee review of the first CAR-T therapy was on the front page of both the Washington Post and the New York Times. Both headlines describe it as a “living drug.”

In the era of Twitter, YouTube and Facebook, making the front page of the Washington Post or the New York Times doesn’t mean as much as it once did.

But it still rare and remarkable that an FDA advisory committee meeting would be covered on the front page of...